FI925210A0 - Kompositioner och foerfaranden foer modulering av rna-molekylens aktivitet genom modifiering av cap-strukturen i rna-molekylens 5'-aenda - Google Patents
Kompositioner och foerfaranden foer modulering av rna-molekylens aktivitet genom modifiering av cap-strukturen i rna-molekylens 5'-aendaInfo
- Publication number
- FI925210A0 FI925210A0 FI925210A FI925210A FI925210A0 FI 925210 A0 FI925210 A0 FI 925210A0 FI 925210 A FI925210 A FI 925210A FI 925210 A FI925210 A FI 925210A FI 925210 A0 FI925210 A0 FI 925210A0
- Authority
- FI
- Finland
- Prior art keywords
- modification
- rna molecular
- rna
- aenda
- foerfaranden
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52759990A | 1990-05-23 | 1990-05-23 | |
| PCT/US1991/003606 WO1991017755A1 (en) | 1990-05-23 | 1991-05-22 | Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI925210A FI925210A (fi) | 1992-11-17 |
| FI925210A0 true FI925210A0 (fi) | 1992-11-17 |
Family
ID=24102143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI925210A FI925210A0 (fi) | 1990-05-23 | 1992-11-17 | Kompositioner och foerfaranden foer modulering av rna-molekylens aktivitet genom modifiering av cap-strukturen i rna-molekylens 5'-aenda |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0531447B1 (el) |
| JP (1) | JPH06500075A (el) |
| KR (1) | KR960004931B1 (el) |
| AT (1) | ATE186464T1 (el) |
| AU (1) | AU649458B2 (el) |
| BR (1) | BR9106486A (el) |
| CA (1) | CA2083377C (el) |
| DE (1) | DE69131773T2 (el) |
| DK (1) | DK0531447T3 (el) |
| ES (1) | ES2139578T3 (el) |
| FI (1) | FI925210A0 (el) |
| GR (1) | GR3032457T3 (el) |
| HU (1) | HUT63568A (el) |
| NO (1) | NO924309L (el) |
| WO (1) | WO1991017755A1 (el) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5789573A (en) * | 1990-08-14 | 1998-08-04 | Isis Pharmaceuticals, Inc. | Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2 |
| ATE218372T1 (de) * | 1993-04-01 | 2002-06-15 | Isis Pharmaceuticals Inc | Antisense oligonnukleotide die mit der mrna cap aktivität interferieren und die translation inhibieren |
| IL114235A0 (en) * | 1994-07-14 | 1995-10-31 | Schering Ag | Oligonucleotide conjugates and processes for noninvasive diagnosis utilizing the same |
| US6380169B1 (en) * | 1994-08-31 | 2002-04-30 | Isis Pharmaceuticals, Inc. | Metal complex containing oligonucleoside cleavage compounds and therapies |
| US5962271A (en) * | 1996-01-03 | 1999-10-05 | Cloutech Laboratories, Inc. | Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end |
| WO2001062981A1 (en) * | 2000-02-25 | 2001-08-30 | Montclair Group | Platform for the discovery of the bacterial genes involved in rna modification |
| KR101881596B1 (ko) | 2008-12-02 | 2018-07-24 | 웨이브 라이프 사이언시스 재팬 인코포레이티드 | 인 원자 변형된 핵산의 합성 방법 |
| CN102596204B (zh) | 2009-07-06 | 2016-11-23 | 波涛生命科学有限公司 | 新的核酸前药及其使用方法 |
| WO2012039448A1 (ja) | 2010-09-24 | 2012-03-29 | 株式会社キラルジェン | 不斉補助基 |
| ES2626488T3 (es) | 2011-07-19 | 2017-07-25 | Wave Life Sciences Pte. Ltd. | Procedimientos para la síntesis de ácidos nucleicos funcionalizados |
| EP2873674B1 (en) | 2012-07-13 | 2020-05-06 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant |
| AU2013288048A1 (en) | 2012-07-13 | 2015-01-22 | Wave Life Sciences Ltd. | Asymmetric auxiliary group |
| SG11201500232UA (en) | 2012-07-13 | 2015-04-29 | Wave Life Sciences Pte Ltd | Chiral control |
| EP3095459A4 (en) | 2014-01-15 | 2017-08-23 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant having antitumor effect and antitumor agent |
| US10322173B2 (en) | 2014-01-15 | 2019-06-18 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent |
| EP3095461A4 (en) | 2014-01-15 | 2017-08-23 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator |
| CN106068325B (zh) | 2014-01-16 | 2021-07-09 | 波涛生命科学有限公司 | 手性设计 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4806463A (en) * | 1986-05-23 | 1989-02-21 | Worcester Foundation For Experimental Biology | Inhibition of HTLV-III by exogenous oligonucleotides |
| CA2073500C (en) * | 1990-01-11 | 2008-03-25 | Phillip Dan Cook | Compositions and methods for detecting and modulating rna activity and gene expression |
-
1991
- 1991-05-22 WO PCT/US1991/003606 patent/WO1991017755A1/en active IP Right Grant
- 1991-05-22 EP EP91911934A patent/EP0531447B1/en not_active Expired - Lifetime
- 1991-05-22 DE DE69131773T patent/DE69131773T2/de not_active Expired - Fee Related
- 1991-05-22 AU AU80802/91A patent/AU649458B2/en not_active Expired
- 1991-05-22 AT AT91911934T patent/ATE186464T1/de not_active IP Right Cessation
- 1991-05-22 KR KR1019920702920A patent/KR960004931B1/ko not_active IP Right Cessation
- 1991-05-22 ES ES91911934T patent/ES2139578T3/es not_active Expired - Lifetime
- 1991-05-22 HU HU923659A patent/HUT63568A/hu unknown
- 1991-05-22 BR BR919106486A patent/BR9106486A/pt not_active Application Discontinuation
- 1991-05-22 CA CA002083377A patent/CA2083377C/en not_active Expired - Lifetime
- 1991-05-22 DK DK91911934T patent/DK0531447T3/da active
- 1991-05-22 JP JP3511198A patent/JPH06500075A/ja active Pending
-
1992
- 1992-11-09 NO NO92924309A patent/NO924309L/no unknown
- 1992-11-17 FI FI925210A patent/FI925210A0/fi not_active Application Discontinuation
-
2000
- 2000-01-25 GR GR20000400151T patent/GR3032457T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU649458B2 (en) | 1994-05-26 |
| HU9203659D0 (en) | 1993-04-28 |
| DK0531447T3 (da) | 2000-03-27 |
| ES2139578T3 (es) | 2000-02-16 |
| EP0531447A4 (en) | 1993-08-11 |
| CA2083377C (en) | 2002-11-26 |
| EP0531447B1 (en) | 1999-11-10 |
| ATE186464T1 (de) | 1999-11-15 |
| BR9106486A (pt) | 1993-05-25 |
| CA2083377A1 (en) | 1991-11-24 |
| EP0531447A1 (en) | 1993-03-17 |
| AU8080291A (en) | 1991-12-10 |
| JPH06500075A (ja) | 1994-01-06 |
| NO924309D0 (no) | 1992-11-09 |
| NO924309L (no) | 1992-11-09 |
| HUT63568A (en) | 1993-09-28 |
| WO1991017755A1 (en) | 1991-11-28 |
| FI925210A (fi) | 1992-11-17 |
| KR960004931B1 (ko) | 1996-04-18 |
| GR3032457T3 (en) | 2000-05-31 |
| DE69131773T2 (de) | 2000-03-02 |
| KR930700118A (ko) | 1993-03-13 |
| DE69131773D1 (de) | 1999-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI925210A (fi) | Kompositioner och foerfaranden foer modulering av rna-molekylens aktivitet genom modifiering av cap-strukturen i rna-molekylens 5'-aenda | |
| DE69433626D1 (de) | N-2 substituierte purine | |
| ATE174599T1 (de) | Bindungskompetente oligomere, die 2',5'-bindungen enthalten | |
| WO1998011243A3 (en) | Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein | |
| DK288183D0 (da) | Fremgangsmade til fremstilling af et oligonucleotidt terapeutisk middel | |
| ES2185695T3 (es) | Terapia genica dirigida. | |
| DE69634698D1 (de) | Gewebespezifische und ziel-rna-spezifische ribozyme | |
| MA20411A1 (fr) | Procede de preparation de polypeptides ayant l'activite du gamma-interferon humain | |
| KR950700079A (ko) | 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease) | |
| KR920004570A (ko) | 사람 mk 단백질을 암호하는 유전자, 이를 포함하는 발현 벡터 및 숙주 세포, mk단백질의 생산 방법 및 사용방법 | |
| WO1998032846A3 (en) | Enzymatic nucleic acid treatment of diseases or conditions related to levels of c-fos | |
| FI103577B1 (fi) | Menetelmä, DNA ja mikro-organismi trombolyyttisen aineen valmistamiseksi | |
| DE69333812D1 (de) | Endo-Xyloglucan-Transferase | |
| DE19681032D2 (de) | Gentherapeutisches Nukleinsäurekonstrukt, seine Herstellung und Verwendung zur Behandlung von Herzerkrankungen | |
| WO2000029589A8 (en) | Methioninase gene therapy for tumor treatment | |
| DE69433996D1 (de) | Verwendung pharmazeutischer zusammensetzungen zur behandlung von neurodegenerativen krankheiten | |
| ATE209683T1 (de) | Planze resistent gegen mindestens zwei viren und dessen preparation | |
| AU7974791A (en) | Identification of novel drugs and reagents | |
| ATE218372T1 (de) | Antisense oligonnukleotide die mit der mrna cap aktivität interferieren und die translation inhibieren | |
| DK1235916T3 (da) | Isolerede polynukleotider med et formindsket indhold af 5'CpG3' epigenitiske kontrolmotiver og anvendelser deraf | |
| WO1993013204A3 (de) | Mittel zur stimulierung der teilungsaktivität tierischer zellen | |
| AU2782989A (en) | Dna and rna molecules stabilized by modifications of the 3'-terminal phosphodiester linkage and their use as nucleic acid probes and as therapeutic agents to block the expression of specifically targeted genes | |
| UA10281C2 (uk) | Спосіб отримання речовини для лікування захворювань підшлункової залози | |
| EP1074619A3 (en) | Promoter for neuropeptide FF and use thereof for therapy and diagnostics | |
| Gallagher et al. | Enzymic cleavage of purine ultraviolet photoproducts formed at biologically significant wavelengths |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |